scispace - formally typeset
C

C. Herrmann

Researcher at International Agency for Research on Cancer

Publications -  5
Citations -  3392

C. Herrmann is an academic researcher from International Agency for Research on Cancer. The author has contributed to research in topics: Population & Cancer. The author has an hindex of 4, co-authored 4 publications receiving 2102 citations.

Papers
More filters
Journal ArticleDOI

Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.

Claudia Allemani, +594 more
- 17 Mar 2018 - 
TL;DR: For most cancers, 5-year net survival remains among the highest in the world in the USA and Canada, in Australia and New Zealand, and in Finland, Iceland, Norway, and Sweden, while for many cancers, Denmark is closing the survival gap with the other Nordic countries.
Journal ArticleDOI

European guidelines for quality assurance in colorectal cancer screening and diagnosis : Overview and introduction to the full Supplement publication.

L. von Karsa, +113 more
- 01 Jan 2013 - 
TL;DR: An overview of the principles, recommendations and standards in the guidelines for quality assurance in CRC screening and diagnosis are presented in journal format in an open-access Supplement of Endoscopy.
Journal ArticleDOI

Worldwide comparison of survival from childhood leukaemia for 1995-2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries.

Audrey Bonaventure, +508 more
TL;DR: Global inequalities in survival from childhood leukaemia have narrowed with time but remain very wide for both ALL and AML, which provides useful information for health policy makers on the effectiveness of health-care systems and for cancer policy makers to reduce inequalities in childhood cancer survival.
Journal ArticleDOI

Survival variations by country and age for lymphoid and myeloid malignancies in Europe 2000-2007: Results of EUROCARE-5 population-based study.

Roberta De Angelis, +210 more
TL;DR: This work provides survival estimates for clinically relevant haematological malignancies (HM), using the International Classification of Diseases for Oncology 3, by country, gender and age in Europe, and finds that population based survival by morphological sub-type is important for measuring outcomes of HM management.
Journal ArticleDOI

Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000-14 (CONCORD-3): analysis of individual data from 258 cancer registries in 61 countries.

N. Ssenyonga, +585 more
TL;DR: In this paper , the authors examined worldwide trends in survival from leukaemia, by age and morphology, in young patients (aged 0-24 years) diagnosed with a haematological malignancy during 2000-14 in 61 countries.